Secure checkout
Join our notification list for verified updates about generic Semaglutide availability and pricing in Canada.
Be among the first notified when these cost-effective generic Semaglutide options become available for dispensing.
Receive advance notice of anticipated price reductions as additional generic manufacturers enter the market.
Signing up is completely free and positions you to take full advantage of savings on this widely-used GLP-1 medication.
We will share confirmed availability and pricing information with waitlist members as it becomes available. Joining the list does not reserve medication or guarantee supply.
Semaglutide is the active ingredient in medications including Ozempic® and Wegovy®. Generic products may become available after receiving the required regulatory authorization.
Once key patents and data protection periods expire, the door opens to competition. This increased competition is projected to drive prices for Semaglutide-based GLP-1 medications down considerably as multiple manufacturers begin production.
Absolutely. Generic medications are not inferior copies. Authorized generic medications must meet applicable Canadian regulatory requirements for quality, safety, and efficacy. Ask your prescriber or pharmacist whether a specific product is appropriate for you.
The government and generic manufacturers operate within a pricing structure designed to reduce costs for patients. Prices are expected to decrease in phases as additional generic options gain approval and enter the market, fostering competition and maximizing patient savings.
We do not yet have a confirmed date. We will notify waitlist members when authorized products, pricing, and supply information are confirmed.
Be first to know when affordable Semaglutide is available
